Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Imprimis Phar (IMMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Harrow Health Announces Fourth Quarter 2018 Financial Results

Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2018.

IMMY : 5.69 (+9.63%)
HROW : 5.56 (+6.72%)
Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019

Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending the 31st Annual ROTH Conference March 18-19, 2019 at The Ritz Carlton, Laguna Niguel in Dana Point, CA. Mark L. Baum, the company's...

IMMY : 5.69 (+9.63%)
HROW : 5.56 (+6.72%)
Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019

Harrow Health, Inc. (NASDAQ: HROW) today announced it will release fourth quarter 2018 financial results after the close of trading on Tuesday, March 12, 2019. The company will host a conference call...

IMMY : 5.69 (+9.63%)
HROW : 5.56 (+6.72%)
Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations

Melt Pharmaceuticals, Inc., a specialty pharmaceutical company recently deconsolidated from Harrow Health, Inc. (NASDAQ: HROW), today announced the U.S. Patent and Trademark office has issued two additional...

IMMY : 5.69 (+9.63%)
HROW : 5.56 (+6.72%)
Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property

Harrow Health, Inc. (NASDAQ: HROW), today announced that its subsidiary, Mayfield Pharmaceuticals, Inc., has acquired drug formulation assets and intellectual property, including three recently issued...

IMMY : 5.69 (+9.63%)
HROW : 5.56 (+6.72%)
Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary

Melt Pharmaceuticals, Inc., an affiliated company of Harrow Health, Inc. (NASDAQ: HROW), today announced it has entered into definitive stock purchase agreements with accredited and institutional investors...

IMMY : 5.69 (+9.63%)
KERX : 3.36 (-2.04%)
HROW : 5.56 (+6.72%)
AMAG : 12.45 (-1.74%)
Best Sector of 2018 and its Hit ETFs & Stocks

Healthcare was the best-performing sector of 2018 and we have highlighted top-performing ETFs and stocks from this sector.

HEMA : 15.0000 (+1.42%)
IMMY : 5.69 (+9.63%)
XLV : 91.85 (-0.15%)
VHT : 174.11 (-0.11%)
XHE : 80.31 (-0.41%)
TNDM : 71.31 (-2.52%)
PRQR : 15.02 (-1.05%)
IHI : 228.77 (-0.82%)
CDNA : 35.85 (+0.73%)
PSCH : 117.97 (+0.38%)
Best Sector of 2018 and its Hit ETFs & Stocks

Healthcare was the best-performing sector of 2018 and we have highlighted top-performing ETFs and stocks from this sector.

HEMA : 15.0000 (+1.42%)
IMMY : 5.69 (+9.63%)
XLV : 91.85 (-0.15%)
VHT : 174.11 (-0.11%)
XHE : 80.31 (-0.41%)
TNDM : 71.31 (-2.52%)
PRQR : 15.02 (-1.05%)
IHI : 228.77 (-0.82%)
CDNA : 35.85 (+0.73%)
PSCH : 117.97 (+0.38%)
Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.

Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ: IMMY) announced it has formally changed its name and that it will trade as "HROW" on The NASDAQ Capital Markets beginning...

IMMY : 5.69 (+9.63%)
HROW : 5.56 (+6.72%)
Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Abeona Therapeutics Inc. (NASDAQ:ABEO),...

IMMY : 5.69 (+9.63%)
CYTK : 8.23 (+5.65%)
AUPH : 6.27 (unch)
LNT : 47.10 (-0.63%)
GLDD : 8.50 (+1.31%)
ABEO : 8.09 (-0.12%)
4 Healthcare Stocks Taking a New Approach to Growth Trends

CORAL GABLES, FL / ACCESSWIRE / November 19, 2018 / have rallied during the last 3 trading sessions. The Select Sector SPDR Healthcare ETF (XLV) has climbed from lows of $88.83 on Thursday to as high...

IMMY : 5.69 (+9.63%)
LCI : 7.88 (-3.79%)
AEZS : 4.00 (+1.01%)
PHGI.CN : 0.760 (+1.33%)
PHGRF : 0.5520 (-3.93%)
Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte's 2018 Technology Fast 500(TM)

Imprimis attributes growth to its vision of making sure patients have access to high quality affordable medications

IMMY : 5.69 (+9.63%)
ETON : 7.60 (+1.33%)
4 Healthcare Stocks Investors Should Get Familiar With

CORAL GABLES, FL / ACCESSWIRE / November 14, 2018 / The is the sector of the economy made up of companies that specialize in products and services related to health and medical care. According to reports...

IMMY : 5.69 (+9.63%)
TDOC : 63.10 (+0.38%)
RSLS : 0.3480 (+2.35%)
Imprimis: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Tuesday reported a loss of $2.5 million in its third quarter.

IMMY : 5.69 (+9.63%)
Imprimis Pharmaceuticals Announces Third Quarter 2018 Results

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018.

IMMY : 5.69 (+9.63%)
ETON : 7.60 (+1.33%)
Imprimis: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Tuesday reported a loss of $3.5 million in its first quarter.

IMMY : 5.69 (+9.63%)
Imprimis Pharmaceuticals Announces First Quarter 2018 Results

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported financial results for the first quarter 2018.

IMMY : 5.69 (+9.63%)
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners

Surface Pharmaceuticals, Inc., an affiliated company of Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), today announced it has entered into a definitive stock purchase agreement with an affiliate of Flying...

IMMY : 5.69 (+9.63%)
Research Report Identifies Albany International, JBG SMITH Properties, Preferred Apartment Communities, National Western Life Group, Phibro Animal Health, and Imprimis Pharmaceuticals with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Albany International Corporation...

APTS : 15.81 (-0.57%)
NWLI : 280.31 (+0.39%)
IMMY : 5.69 (+9.63%)
AIN : 73.74 (+1.54%)
JBGS : 41.29 (-0.72%)
PAHC : 32.07 (+1.71%)
Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), and its ophthalmology-focused ImprimisRx division, today announced its participation and related physician presentations at the 2018 American Society of Cataract...

IMMY : 5.69 (+9.63%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.02
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar